Skip to main content

Table 2 Right ventricular global (average) strain values stratified by diagnostic groupd

From: Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/ cardiomyopathy: a multisoftware feasibility and clinical implementation study

  Overt ARVD/C (N = 39) Preclinical ARVD/C (N = 40) Controls
(N = 31)
P-Valuec
MEDIS −17.6 ± 6.3ab −21.8 ± 4.6 −21.4 ± 5.5 0.001
TOMTEC −14.3 ± 7.1ab −17.7 ± 6.6 −17.8 ± 5.6 0.057
MTT −19.3 ± 6.2ab −26.2 ± 5.0 −27.7 ± 5.5 <0.001
CIRCLE −21.3 ± 5.3 a −22.9 ± 3.7 −23.7 ± 2.3 0.065
  1. a Statistical significant difference compared to control subjects; b = Statistical significant difference compared to preclinical subjects; c = Trend between overt ARVD/C patients, preclinical ARVD/C and control subjects (OneWay ANOVA). Abbreviations: ARVD/C = Arrhythmogenic Right Ventricular Dysplasia/ Cardiomyopathy; MTT = Multimodality Tissue Tracking; N = number of subjects
  2. d Segments included based on adequate tracking quality: 365/438, 429/468, and 328/360 segments in overt ARVD/C, preclinical ARVD/C and control subjects respectively